loading

Keros Therapeutics Inc Stock (KROS) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
41.96%
0.083
0.143 0.008 - -
Operating Expenses
4.22%
48.57
46.60 43.29 41.34 38.87
Benefits Costs and Expenses
100.00%
-
153.14 - - -
Costs And Expenses
63.80%
48.57
29.65 43.29 - -
Operating Income/Loss
4.37%
-48.48
-46.45 -43.28 -41.34 -38.87
Nonoperating Income/Loss
13.57%
5.369
6.212 3.84 3.832 3.065
Income/Loss From Continuing Operations Before Tax
100.05%
0.083
-153.00 0.008 -37.51 -35.80
Income/Loss From Continuing Operations After Tax
7.13%
-43.11
-40.24 -39.44 -37.51 -35.80
Net Income/Loss
7.13%
-43.11
-40.24 -39.44 -37.51 -35.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
15,485%
35.69
0.229 29.67 29.60 28.37
Diluted Average Shares
15,485%
35.69
0.229 29.67 29.60 28.37
Basic Earnings Per Share
9.70%
-1.21
-1.34 -1.33 -1.27 -1.26
Diluted Earnings Per Share
9.70%
-1.21
-1.34 -1.33 -1.27 -1.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):